Add to ORKGWe read the recent article published in your journal on the predictors of mortality in patients with coronavirus 2019 (COVID‐19) infection with great interest
Rationale: Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor block...
Background: There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and a...
Introduction A new coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), wa...
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs)...
Background: Conflicting findings and the analysis of unpublished and retracted data have led to cont...
BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs...
Background Concerns have been raised that angiotensin-converting enzyme-inhibitors (ACE-I) and angio...
Background: Hypertension is the main factor to predict the severity and mortality of COVID-19. The u...
OBJECTIVES: The widespread use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin r...
Initially reported in China at the end of 2019, the coronavirus pandemic has now reached an internat...
Introduction: Angiotensin converting enzyme inhibitors (ACEs) and angiotensin receptor blockers (ARB...
AimsThe aim of this study was to continually evaluate the association between cardiovascular drug ex...
Targeting the renin-angiotensin system is proposed to affect mortality due to coronavirus disease 20...
The possible effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor ...
Background: The are conflicting reports on the effects of angiotensin-converting enzyme inhibitors (...
Rationale: Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor block...
Background: There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and a...
Introduction A new coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), wa...
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs)...
Background: Conflicting findings and the analysis of unpublished and retracted data have led to cont...
BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs...
Background Concerns have been raised that angiotensin-converting enzyme-inhibitors (ACE-I) and angio...
Background: Hypertension is the main factor to predict the severity and mortality of COVID-19. The u...
OBJECTIVES: The widespread use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin r...
Initially reported in China at the end of 2019, the coronavirus pandemic has now reached an internat...
Introduction: Angiotensin converting enzyme inhibitors (ACEs) and angiotensin receptor blockers (ARB...
AimsThe aim of this study was to continually evaluate the association between cardiovascular drug ex...
Targeting the renin-angiotensin system is proposed to affect mortality due to coronavirus disease 20...
The possible effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor ...
Background: The are conflicting reports on the effects of angiotensin-converting enzyme inhibitors (...
Rationale: Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor block...
Background: There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and a...
Introduction A new coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), wa...